Skip to main content

As of February 2020, the FDA issued the following warning:

“The U.S. Food and Drug Administration (FDA) has requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market because a safety clinical trial shows an increased occurrence of cancer. The drug manufacturer, Eisai Inc,. has submitted a request to voluntarily withdraw the drug.”

The FDA has taken this action because they believe the risks of lorcaserin outweigh its benefits. For more information regarding the FDA’s actions in association with the weight loss drug, BELVIQ and BELVIQ XR, visit

If you or a loved one has suffered side effects from this drug, contact Judson Graham Firm today to speak with an attorney as you may qualify to file a lawsuit to seek compensation for your damages and injuries.

Leave a Reply